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Objective: Concentrations of cortisol in hair, a novel marker of longer-term cortisol status, were 
compared in depressed versus nondepressed patients with coronary artery disease (CAD).
Methods: 20 mg hair samples of 3 cm length were collected from 121 patients attending a 
cardiac rehabilitation program, 34 of whom suffered from depressive symptoms.
Results: Controlling for age, gender, coronary artery bypass grafting, history of depression, 
and time since most recent acute coronary syndrome, cortisol concentrations (P = 0.162) did 
not predict severity of depression. Younger age (P = 0.003) was a significant predictor of 
  depressive symptoms. Perceived stress was not associated with long-term cortisol   concentrations 
(P = 0.161).
Conclusions: Cortisol concentrations in hair do not predict depressive symptoms in CAD 
patients attending cardiac rehabilitation.
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Introduction
The prevalence of depression in the general population ranges from 4.4% to 20%, 
but the prevalence in patients with coronary artery disease (CAD) is at least 2-fold 
higher.1–3 About 20% of patients with CAD suffer from major depression (MD) within 
1 year following an acute coronary syndrome (ACS) while another 27% do not meet 
diagnostic criteria but show depressive symptoms or suffer from minor depression.4–6 
In those with CAD, depressive comorbidity is associated with an increased risk of 
mortality and medical morbidity independent of traditional cardiac risk factors,7–10 and 
can significantly affect recovery after a major ACS.11,12 Depression also has a negative 
impact on rehabilitation outcomes such as medication adherence,13 cardiopulmonary 
fitness,14,15 psychosocial rehabilitation,16,17 and overall quality of life.9 Moreover, clinical 
studies of depression in CAD patients show poor response rates and residual symptoms 
following treatment with selective serotonin reuptake inhibitors.18,19 Understanding the 
etiology of depression associated with CAD is therefore of clinical importance.
It has been shown that depressive symptoms and psychological stress tend to 
decline over the course of cardiac rehabilitation in concert with an increase in quality 
of life, while cardiac risk factor profiles improve concurrently, reducing mortality and 
morbidity.20–25 However, symptoms may persist in many patients with depression. Stud-
ies have shown that 95% of patients with untreated MD following myocardial infarc-
tion (MI) will remain depressed at six months, and up to 70% will remain depressed 
at 1 year.2,26 The reasons why only some patients remain chronically depressed are 
not understood.
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High concentrations of cortisol, the main steroid   hormone 
associated with the stress response system, have been detected 
in patients with depression.27–30 Ongoing   elevations have also 
been associated with risk factors for CAD,   including high 
blood pressure, elevated heart rate, higher waist-to-hip ratio, 
insulin resistance, diabetes, elevated total and LDL   cholesterol, 
and decreased HDL cholesterol.31–33 The   relationship between 
cortisol and depression may be particularly important in CAD 
patients, because elevated   concentrations of cortisol due to 
  hypothalamic-pituitary-adrenal (HPA) axis hyperactivity 
may be associated with an increased risk of mortality and 
medical comorbidity.31,34–36 Ongoing activation of the HPA 
axis and high   concentrations of cortisol may also be important 
in the persistence of   depressive symptoms.
Typically, concentrations of cortisol in the   bloodstream are 
subject to diurnal variation. Normally, cortisol   concentrations 
peak in the morning and subside in the evening, with the low-
est concentrations occurring around midnight.37,38 However, 
in depressed patients this pattern is disrupted and, instead, 
cortisol peaks earlier in the morning and decreases less in the 
evening, resulting in increased systemic cortisol exposure.39
Previously, cortisol measurements in saliva, plasma, and 
urine, have shown short-term changes in the hormone over 
a period of up to 24 hours.40,41 These methods are   validated 
  measures of acute stress, but they are subject to the   normal 
diurnal variation in cortisol secretion, and are easily affected 
by temporary or transient disturbances in   psychosocial 
stress on the day of measurement.   Biopsychosocial stressors 
  associated with CAD, however, are likely to be chronic. 
Therefore, in order to better understand the association 
between cortisol levels and depression in CAD,   long-term 
measurement of cortisol may be more appropriate, 
  necessitating multiple blood, saliva, or urine samples.42
Recently, a new method has been developed to measure 
cortisol in hair samples. Because hair grows at a rate of about 
1 cm per month, hair cortisol concentrations may provide a 
long-term measure of cortisol, thereby obviating the need 
for frequent sampling.43 This method has been validated and 
shown to be significantly correlated with 24-hour urinary 
cortisol, therefore having an ability to be used as a biomarker 
for long-term measurements.43 This method has also been 
validated in a postpartum sample where hair cortisol was 
shown to capture the known increased production of cortisol 
during the third trimester.44 The relationship between stress 
and elevated levels of cortisol in hair has also been shown. 
In a study by Van Uum et al in patients with chronic pain, 
hair cortisol was higher in patients with major chronic pain.45 
Moreover, in a recent study, hair cortisol measurements were 
done in patients with Cushing’s syndrome, and results indi-
cated that hair cortisol levels were significantly higher than 
that in healthy controls.46
The objective of this study was to investigate the 
  relationship between depressive symptoms and long-term 
hair concentrations of cortisol in CAD patients.
Methods
subjects and setting
This was a cross-sectional study of sequentially recruited 
subjects attending the Toronto Rehabilitation Institute 
Cardiac Rehabilitation and Secondary Preven  tion Pro-
gram (TRI-Cardiac). All experiments on human subjects 
were   conducted in accordance with the Declaration of 
  Helsinki.47 All participants gave written informed consent 
before   inclusion in the study. This study was approved by 
the local Research Ethics Boards. Demographic details 
and medical history were obtained by electronic chart 
review.
CAD subjects were identified based on a history of MI, 
coronary angiographic evidence of $50% blockage in at least 
one major coronary artery, or prior revascularization, such 
as percutaneous coronary intervention (PCI) procedures or 
coronary artery bypass graft (CABG) surgery at the time of 
enrolment at the TRI-Cardiac. All CAD patients had entered 
cardiac rehabilitation a minimum of 6–8 weeks post-CABG 
(6 weeks for uncomplicated CABG), a minimum of 6 weeks 
post-MI, or a minimum of 3 weeks post-PCI.   TRI-Cardiac 
involves a 1-year exercise program   consisting of both aerobic 
and resistance training in a group setting with supervision by 
exercise and medical specialists. Patients were excluded if they 
had a significant acute medical illness such as cancer, Parkin-
son’s disease, or multiple sclerosis, if a premorbid psychiatric 
diagnosis of schizophrenia or bipolar disorder was present, 
or if they had significant cognitive impairment.
Patients were recruited either at entry into the r  ehabilitation 
program or at the time of completion of the program after 
one year to coincide with aerobic testing.
Diagnosis of depression
Depression was diagnosed based on patient history and on 
a structured clinical interview for depression   according to 
the Diagnostic and Statistical Manual of Mental   Disorders 
version IV (DSM-IV-TR) performed at the time of cortisol 
sampling.48,49 Criteria for diagnosing a major depression 
included either depressed mood or anhedonia, in c  ombination 
with changes in appetite and/or weight, insomnia or 
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feelings of worthlessness or guilt, diminished   ability to think 
or being indecisive, or current thoughts of own death. Subjects 
satisfying 5 of 9 criterion   symptoms for 2 weeks, including 
either sadness or anhedonia, were   diagnosed as having MD. 
Subjects were diagnosed with minor   depression if they sat-
isfied 3 criteria, 1 of which was sadness or anhedonia. The 
presence of a personal or family history of depression was 
also collected from the subjects.
Severity of depressive symptoms was measured using 
the Center for Epidemiological Studies Depression Scale 
(CES-D),50 a 20-item depression inventory scored from 
0 (least depressed) to 60 (most depressed). This scale has 
been used extensively in CAD populations.15,51
stress measurement
Long-term subjective stress was measured using the   Perceived 
Stress Scale (PSS),52 a 10-item self-report   instrument scored 
from 0 to 40 that gauges psychological stress responses 
within the past month. The survey items are short and easy to 
understand, and this scale has been used widely to investigate 
relationships with cortisol.53 Time since most recent ACS was 
also documented as a source of stress and was controlled for 
in analyses.
hair samples
A 20 mg hair sample, 3 cm in length (as a measure of   average 
cortisol over the previous 3-month period), was   collected by 
study personnel. All samples were collected from the   vertex 
posterior as close to the scalp as possible using   fine-tipped 
surgical scissors as per our standard   protocol. It has previously 
been demonstrated that cortisol   concentrations are not affected 
by natural hair color nor by dying of the hair.43,45,53
cortisol assays
Each sample was weighed and minced finely with scissors. 
Afterwards, 1 mL of methanol was added, and the   suspension 
was sonicated for 30 minutes and then incubated overnight 
for 16 hours at 52°C. After incubation, the methanol was 
removed from each sample and placed in a glass tube and 
evaporated in a dry bath under a stream of nitrogen gas. Upon 
evaporation of methanol, 250 µL of   phosphate-buffered saline 
solution at pH 8.0 was added to the sample and vortexed until 
well mixed.43 Cortisol measurement was performed using 
the salivary enzyme-linked immunosorbent assay cortisol 
kit (Alpco Diagnostics, New Hampshire, US). The extracts 
were run on the assay according to the instructions from the 
manufacturer.43 Patients with cortisol concentrations over 
1500 ng/g were excluded because these levels are suggestive 
of Cushing’s syndrome or contamination by cream   containing 
hydrocortisone.54
statistical analysis
Continuous variables were summarized using   independent 
samples t-tests and reported as means ± SD, whereas 
  categorical measures were summarized using chi-square 
tests and report as counts and percentages.
The association between cortisol and depression as a 
  categorical variable was assessed using analysis of   covariance 
(ANCOVA). Given that there were 34 patients in the “depressed” 
cohort, only 4 variables could be used in the model, ie, history of 
depression, marital status, and age in addition to cortisol. This 
selection was based on strength of association with depression 
(see Table 1), and minimal multicollinearity.
Linear regression was performed between depressive 
symptoms as a continuous variable, using CES-D scores, 
and cortisol, with covariates of interest such as age, gender, 
marital status, and time since most recent ACS. Linear 
  regression was also used to assess the association between 
stress, as measured by PSS scores as a continuous variable, 
and concentrations of cortisol, with covariates of interest such 
as age, gender, marital status, and time since most recent 
ACS in CAD patients.
Since both the presence of depression and depression 
severity were assessed as primary outcomes, the Bonferroni 
correction was used in all analyses. Significance was set at 
P , 0.025 (0.05/2).
Hair cortisol concentrations were not normally distributed 
among patients and were transformed to a logarithmic scale 
for all analyses.
Results
subjects
Of 246 patients attending cardiac rehabilitation who were 
approached for participation, 141 CAD patients were 
recruited. Fourteen patients were excluded because they had 
insufficient hair for analysis. One hundred and twenty-seven 
patients provided hair samples that were analyzed for cortisol 
concentration. Of these patients, 6 were excluded because 
their hair cortisol concentration was higher than 1500 ng/g.54 
Therefore, 121 CAD patients were included in this study. 
Of these, 34 were depressed and 87 were not depressed (see 
Figure 1). The sociodemographic characteristics of these 
patients are summarized in the Table 1.
As expected, mean CES-D scores were significantly higher 
in depressed patients compared with nondepressed patients 
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mean PSS scores (F = 1.81, df     = 118, P , 0.0005). In addition, 
there were trends for depressed patients to be slightly younger, 
unmarried, and female, and significantly greater proportions of 
depressed patients were taking anxiolytics (see Table 1).
Assay results
All collected hair samples were of adequate weight for 
analysis of cortisol. Hair color and hair dye data were col-
lected from 83 of 121 samples; among these 34 were grey, 
14 white, 14 black, 18 brown, and 3 blonde hair samples. The 
log-transformed mean hair cortisol concentration among the 
samples that had applied hair dye (n = 5) and the ones who 
have not been treated with dye (n = 78) was not significantly 
different (4.77 ± 0.70 versus 4.95 ± 0.57, F = 0.49, df = 81, 
P = 0.49). The log-transformed mean cortisol concentration 
for nondepressed patients (n = 87) was 5.04 ± 0.59, and 
Table 1 Patient characteristics (n = 121)
Nondepressed 
(n = 87)
Depressed 
(n = 34)
Significance 
P value
Sociodemographic
    Age in years 
(mean ± sD)
65.7 ± 11.1 61.6 ± 12.9 0.09
    employment 
(% employed)
51.7 47.1 0.64
    Marital status 
(% married)
81.6 58.8 0.01*
  sex (% male) 80.5 64.7 0.07
    smoking status 
(% current smoker)
3.4 0 0.33
    Weeks since cardiac  
event (mean ± sD)
34.4 ± 36.4 38.6 ± 33.3 0.56
Anthropometric
    BMi (kg/m²) 
(mean ± sD)
27.5 ± 4.9 28.5 ± 6.5 0.32
    Weight (lb) 
(mean ± sD)
178.0 ± 37.5 174.1 ± 38.9 0.61
Physiology
    systolic blood  
pressure 
(mean ± sD)
130.8 ± 17.8 124.1 ± 17.8 0.07
    Diastolic blood  
pressure 
(mean ± sD)
73.6 ± 10.8 74.3 ± 9.1 0.74
Cardiac factors n (%)
    Myocardial infarction 39 (44.8) 15 (44.1) 0.94
  cABg 30 (34.5) 11 (32.4) 0.82
  Pci 39 (44.8) 13 (38.2) 0.51
  Angina pectoris 22 (25.3) 7 (20.6) 0.58
  hypertension 47 (54.0) 16 (47.1) 0.49
Medical comorbidities n (%)
  Diabetes 22 (25.3) 6 (17.6) 0.37
  renal disease 2 (2.3) 1 (2.9) 1.00
  cOPD 4 (4.6) 2 (5.9) 0.77
  Asthma 3 (3.4) 0 (0.0) 0.27
    history of 
depression
7 (9.6) 10 (33.3) 0.005*
Concomitant medication n (%)
 β -blockers 60 (69.0) 22 (64.7) 0.65
  statins 81 (93.1) 31 (91.2) 0.71
  Nitroglycerin 45 (51.7) 17 (50.0) 0.86
    ca²+ channel 
blockers
19 (21.8) 11 (32.4) 0.23
  Antihypertensives 51 (58.6) 20 (58.8) 0.98
  Platelet inhibitors 80 (92.0) 32 (94.1) 1.00
Psychotropic medications n (%)
  Anxiolytics 5 (5.7) 8 (23.5) 0.008*
  Antidepressants 3 (3.4) 3 (8.8) 0.35
Scales
    ces-D score  
(mean ± sD)
6.5 ± 4.8 24.5 ± 10.1 ,0.005*
    Pss score  
(mean ± sD)
10.6 ± 6.7 21.0 ± 5.5 ,0.005*
*Statistically significant.
Abbreviations:  BMi,  body  mass  index;  cABg,  coronary  artery  bypass  graft; 
ces-D, center for epidemiological studies Depression; cOPD, chronic obstructive 
pulmonary disease; Pci, percutaneous coronary intervention; Pss, Perceived stress 
scale; sD, standard deviation.
CAD patients
approached at TRI
N = 246
Agreed
N = 195
Eligible
N = 141
Not eligible
N = 54
Insufficient hair
N = 14
Recruited
N = 127
Not interested
N = 51
Cortisone
contamination
N = 6
Included
N = 121
Depressed
N = 34
Non-depressed
N = 87
Figure 1 Flow chart of recruitment process.
Abbreviations:  cAD,  coronary  artery  disease;  Tri,  Toronto  rehabilitation 
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for depressed patients (n = 34) was 4.96 ± 0.58, and the 
values were not significantly different (F = 0.393, df = 119, 
P = 0.53). Mean cortisol concentrations were not different 
between patients assessed at baseline or at completion of 
rehabilitation (P = 0.109, F = 0.260, df = 119).
hair cortisol and depression
There was no significant difference in the concentration of 
hair cortisol between depressed and nondepressed patients 
(P = 0.825) in an ANCOVA controlling for age, marital sta-
tus, and history of depression. Marital status (P = 0.021) and 
history of depression (P = 0.008) remained in the final model 
as the only variables significantly predictive of depression 
(χ2 = 13.26, R2 = 0.172, P = 0.001). Gender, time since most 
recent ACS, and CABG were excluded from the ANCOVA 
based on a lower strength of association (see Table 1).
In a linear regression model predicting severity of 
  depressive symptoms as measured by CES-D scores,   including 
concentrations of cortisol, age, gender, marital status, and 
time since most recent ACS, cortisol was not associated with 
CES-D scores (beta = −0.148, P = 0.162). Gender (beta = 0.042, 
P = 0.678), marital status (beta = 0.021, P = 0.837), CABG 
(beta = −0.035, P = 0.747), and time since most recent ACS 
(beta = 0.019, P = 0.846) were also removed from the model. 
In the final model, younger age (beta = −0.274, P = 0.003) 
was   significantly associated with CES-D scores (R² = 0.088, 
P = 0.004, F = 5.86, df = 101), and personal history of   depression 
trended towards significance (beta = −183, P = 0.059).
In a linear regression model predicting perceived stress, 
including cortisol concentration, age, gender, marital 
  status, CABG, history of depression, and time since most 
recent ACS, cortisol was not associated with PSS scores 
(beta = −0.149, P = 0.161). Gender (beta = 0.124, P = 0.226), 
marital status (beta = −0.080, P = 0.438), history of 
  depression (beta = −0.006, P = 0.957), time since most recent 
ACS (beta = −0.004, P = 0.965), and CABG (beta = −0.057, 
P = 0.597) were also not significantly associated with PSS 
scores. In the final model, only younger age (beta = −0.245, 
P = 0.013) was associated with PSS scores (R² = 0.051, 
P = 0.013, F = 6.41, df = 101).
There were no differences in average concentration 
of cortisol between married versus single participants 
(P = 0.7, F = 0.18, df = 119), males versus females (P = 0.9, 
F = 1.1, df = 119), those with major or minor depression 
(P = 0.6, F = 0.88, df = 31), those recruited at entry or at their 
final visit (P = 0.094, F = 2.850, df = 120), those on or off 
anxiolytic medications (P = 0.3, F = 0.24, df = 119), or those 
with a history of depression (P = 0.17, F = 2.81, df = 101).
There were differences in average concentration of 
  cortisol between those who had CABG and those who did 
not (P = 0.002, F = 1.04, df = 119). This suggests that a 
stressful intervention, such as a CABG, has significant 
effects on   cortisol levels. Another putative source of stress, 
ie, angina, did not have significant effects on total cortisol 
levels (P = 0.642, F = 0.075, df = 119).
Discussion
The present study found no association between long-term 
concentrations of cortisol and depression or perceived stress 
in CAD patients. Single marital status and a positive history 
of depression were found to be significant predictors of the 
presence of depression, as has been found before.55 Similarly, 
cortisol did not predict severity of depressive symptoms or 
perceived stress, and only younger age56 was associated with 
both of these. This study utilized a novel method, cortisol 
deposition in hair, to measure longer-term HPA axis activity. 
Examination of long-term cortisol concentration in hair is 
an important complement to other methods which determine 
short-term changes in cortisol concentrations.
A positive association has previously been documented 
between depression and acute cortisol measurements.57,58 Otte 
et al found an association between 24-hour urinary cortisol 
and depression in outpatients with coronary heart disease.57 
S  imilarly, Bhattacharyya et al reported an impaired diurnal 
pattern of cortisol secretion with flatter cortisol rhythms during 
the day in CAD patients with depression.58 Thus, the results 
from this study using longer-term measurement   contrast with 
those of shorter-term cortisol measurement in CAD. However, 
in a recent study by Whooley et al 24-hour urinary cortisol 
had no significant role in explaining the association between 
depressive symptoms and adverse   cardiovascular events.59
Our findings may reflect widespread cortisol   concentration 
elevations in our population, as has been seen before.60 Mean 
concentrations of cortisol in both our groups of patients 
appear higher compared with concentrations of hair cortisol 
measured in healthy young subjects.54 The higher average 
cortisol concentrations in both depressed and nondepressed 
CAD patients may reflect the ubiquitous presence of 
  cardiovascular risk factors such as hypertension, diabetes, 
and obesity, which may be inherently associated with HPA 
axis dysregulation.32,61,62 In addition, all of our CAD patients 
suffered from a significant event that may have led to ongoing 
psychosocial stress, another factor that can increase cortisol 
concentrations in hair.45,53 While having a recent ACS may 
also be associated with increased cortisol,60 time since ACS 
was not significantly associated with cortisol   concentrations, Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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or perceived stress, suggesting that these elevations 
  persist. The resulting chronic cortisol changes would then 
make it impossible to distinguish between depressed and 
  nondepressed patients using this measure.
Several factors should be considered in interpreting 
these results. Some participants were receiving   concomitant 
  psychotropic medications. In general, there was a low rate of 
antidepressant use among depressed patients in our   population, 
making it unlikely that antidepressant use affected the results. 
Similarly, hair cortisol concentrations did not differ in those 
taking or not taking anxiolytics. The sample size of depressed 
patients was also relatively small, and comprised both those 
with major and minor   depression. However, there were no 
differences in hair cortisol   concentration in those with major 
versus minor depression. Also, given the complete lack of a 
trend for differences between depressed and nondepressed 
groups, power is not a relevant issue here.
We found that those with depressive symptoms had higher 
mean PSS scores. This, and the fact that those with depressive 
symptoms had more use of anxiolytics, suggests comorbid 
  anxiety. Anxiety was not directly investigated in this study. 
Because anxiety and depression commonly co-occur and the 
presence of anxiety may stimulate the HPA axis,63 anxiety 
might be an important cofactor in this population. State and trait 
anxiety should be evaluated in conjunction with depression and 
stress in future studies to better understand this relationship.
It would also be interesting to compare hair   cortisol 
  concentrations in this group of patients with healthy age-
matched controls, and those with MD but no CAD. Long-term 
cortisol in hair has not been measured in solely depressed 
subjects or in different types of depression, including melan-
cholic and nonmelancholic. As a result, it is not clear whether 
the method has the sensitivity to detect changes in HPA axis 
functioning that would be typical of those found in MD. An 
additional limitation of this study is that it is unknown how 
long depressive episodes lasted prior to collection of the hair 
sample. Finally, medical   history was ascertained by chart 
review, and patients were not   specifically questioned about 
somatic diseases such as thyroid dysfunction,64 which could 
disrupt HPA axis function and lead to altered cortisol levels.
Conclusion
This study found no association between chronically elevated 
concentrations of cortisol and depression or stress in CAD 
patients attending rehabilitation. Known   demographic 
  covariates such as marital status, age, and history of 
  depression were significant predictors, and none of these are 
targets for intervention. Depression is a significant problem 
in CAD patients and the biologic factors that may mediate 
this comorbidity remain largely unknown. Further research 
investigating the relationship between depression and CAD 
is warranted.
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